Hepatitis C virus (HCV) replication in infected patients produces large and diverse viral populations, which give rise to drug-resistant and immune escape variants. Here, we analyzed HCV populations during transmission and diversification in longitudinal and cross-sectional samples using 454/Roche pyrosequencing, in total analyzing 174,185 sequence reads. To sample diversity, four locations in the HCV genome were analyzed, ranging from high diversity (the envelope hypervariable region 1 [HVR1]) to almost no diversity (the 5′ untranslated region [UTR]). For three longitudinal samples for which early time points were available, we found that only 1 to 4 viral variants were present, suggesting that productive infection was initiated by a very ...
A precise molecular identification of transmitted hepatitis C virus (HCV) genomes could illuminate k...
Viral sequencing of rapidly mutating RNA viruses such as hepatitis C (HCV) offersopportunities for i...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
Hepatitis C virus (HCV) replication in infected patients produces large and diverse viral population...
Hepatitis C virus (HCV) replication in infected patients produces large and diverse viral population...
In contrast to other available next-generation sequencing platforms, PacBio single-molecule, real-ti...
A precise molecular identification of transmitted hepatitis C virus (HCV) genomes could illuminate k...
Hepatitis C is a pandemic human RNA virus, which commonly causes chronic infection and liver disease...
Hepatitis C virus (HCV) is the leading cause of liver disease worldwide. In this study, we analyzed ...
Molecular characterization of early hepatitis C virus (HCV) infection remains rare. Ten out of 78 pa...
Despite major breakthroughs in the treatment of HCV infection in recent years, we have a limited und...
Background Despite recent breakthroughs in treatment of hepatitis C virus (HCV) infection, we have l...
Hepatitis C virus (HCV) is a medically important RNA virus in the Flaviviridae family. It persists i...
Understanding within-host evolution is critical for predicting viral evolutionary outcomes, yet such...
Abstract Background Intra-host hepatitis C virus (HCV) populations are genetically heterogeneous and...
A precise molecular identification of transmitted hepatitis C virus (HCV) genomes could illuminate k...
Viral sequencing of rapidly mutating RNA viruses such as hepatitis C (HCV) offersopportunities for i...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
Hepatitis C virus (HCV) replication in infected patients produces large and diverse viral population...
Hepatitis C virus (HCV) replication in infected patients produces large and diverse viral population...
In contrast to other available next-generation sequencing platforms, PacBio single-molecule, real-ti...
A precise molecular identification of transmitted hepatitis C virus (HCV) genomes could illuminate k...
Hepatitis C is a pandemic human RNA virus, which commonly causes chronic infection and liver disease...
Hepatitis C virus (HCV) is the leading cause of liver disease worldwide. In this study, we analyzed ...
Molecular characterization of early hepatitis C virus (HCV) infection remains rare. Ten out of 78 pa...
Despite major breakthroughs in the treatment of HCV infection in recent years, we have a limited und...
Background Despite recent breakthroughs in treatment of hepatitis C virus (HCV) infection, we have l...
Hepatitis C virus (HCV) is a medically important RNA virus in the Flaviviridae family. It persists i...
Understanding within-host evolution is critical for predicting viral evolutionary outcomes, yet such...
Abstract Background Intra-host hepatitis C virus (HCV) populations are genetically heterogeneous and...
A precise molecular identification of transmitted hepatitis C virus (HCV) genomes could illuminate k...
Viral sequencing of rapidly mutating RNA viruses such as hepatitis C (HCV) offersopportunities for i...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...